Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys-Reference-Cited by-同舟云学术

Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys

Published:2008-01 Issue:2 Volume:31 Page:229-244
ISSN:0148-0545
Container-title:Drug and Chemical Toxicology
language:en
Short-container-title:Drug and Chemical Toxicology

Author:

Woodburn Kathryn W.,Schatz Peter J.,Fong Kei-lai,Wilson Susan D.,Ferrell Thomas,Spainhour Charles B.,Norton Daniel

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/01480540701873186

Reference20 articles.

1. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat

2. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

3. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

4. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor;Toxicologic Pathology;2019-10-22

2. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits;European Journal of Pharmaceutical Sciences;2018-07

3. Chronic preclinical safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis-stimulating agent in monkeys and rats;Toxicology and Applied Pharmacology;2016-09

4. Safety and Biosimilarity of ior®EPOCIM Compared with Eprex® Based on Toxicologic, Pharmacodynamic, and Pharmacokinetic Studies in the Sprague–Dawley Rat;Journal of Pharmaceutical Sciences;2014-11

5. Subchronic safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis stimulating agent, after 5-week subcutaneous injection in Cynomolgus monkeys and Sprague–Dawley rats;Food and Chemical Toxicology;2013-10